Skip to menu Skip to content Skip to footer

2025

Journal Article

Peripheral and central elevation of IL-8 in patients with Huntington’s disease

Fung, Jenny N., Lee, John D., Adam, Robert, O’Sullivan, John D. and Woodruff, Trent M. (2025). Peripheral and central elevation of IL-8 in patients with Huntington’s disease. Molecular Immunology, 179, 84-93. doi: 10.1016/j.molimm.2025.02.003

Peripheral and central elevation of IL-8 in patients with Huntington’s disease

2025

Journal Article

Clinical utility of 18F-fluorodopa positron emission tomography in the movement disorder clinic: an Australian experience

Yeow, Dennis, Fielder, Matthew, Hynard, Shane, Adam, Robert, Katz, Matthew, Lehn, Alexander, Thomas, Paul and O'Sullivan, John D. (2025). Clinical utility of 18F-fluorodopa positron emission tomography in the movement disorder clinic: an Australian experience. Internal Medicine Journal, 55 (2), 207-215. doi: 10.1111/imj.16615

Clinical utility of 18F-fluorodopa positron emission tomography in the movement disorder clinic: an Australian experience

2024

Journal Article

Profiling people with Parkinson's disease at risk of cognitive decline: Insights from PPMI and ICICLE‐PD data

Pourzinal, Dana, Lawson, Rachael A., Yarnall, Alison J., Williams‐Gray, Caroline H., Barker, Roger A., Yang, Jihyun, McMahon, Katie L., O'Sullivan, John D., Byrne, Gerard J. and Dissanayaka, Nadeeka N. (2024). Profiling people with Parkinson's disease at risk of cognitive decline: Insights from PPMI and ICICLE‐PD data. Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, 16 (3) e12625, 1-11. doi: 10.1002/dad2.12625

Profiling people with Parkinson's disease at risk of cognitive decline: Insights from PPMI and ICICLE‐PD data

2024

Journal Article

Hippocampal resting‐state connectivity is associated with posterior‐cortical cognitive impairment in Parkinson's disease

Pourzinal, Dana, Yang, Jihyun, McMahon, Katie L., Copland, David A., Mitchell, Leander, O'Sullivan, John D., Byrne, Gerard J. and Dissanayaka, Nadeeka N. (2024). Hippocampal resting‐state connectivity is associated with posterior‐cortical cognitive impairment in Parkinson's disease. Brain and Behavior, 14 (3) e3454, 1-12. doi: 10.1002/brb3.3454

Hippocampal resting‐state connectivity is associated with posterior‐cortical cognitive impairment in Parkinson's disease

2024

Journal Article

A physiotherapy group exercise and self-management approach to improve physical activity in people with mild-moderate Parkinson’s disease: a randomized controlled trial

Brauer, Sandra G., Lamont, Robyn M. and O’Sullivan, John D. (2024). A physiotherapy group exercise and self-management approach to improve physical activity in people with mild-moderate Parkinson’s disease: a randomized controlled trial. Trials, 25 (1) 76, 1-10. doi: 10.1186/s13063-023-07870-4

A physiotherapy group exercise and self-management approach to improve physical activity in people with mild-moderate Parkinson’s disease: a randomized controlled trial

2024

Journal Article

Feasibility and acceptability of a videoconferencing CBT intervention for anxiety in people with Parkinson’s Disease

Roper, Amy, Brooks, Deborah, Mitchell, Leander K., Pachana, Nancy A., Au, Tiffany R., Byrne, Gerard J., O’Sullivan, John D. and Dissanayaka, Nadeeka N. (2024). Feasibility and acceptability of a videoconferencing CBT intervention for anxiety in people with Parkinson’s Disease. Clinical Gerontologist, 1-16. doi: 10.1080/07317115.2024.2306861

Feasibility and acceptability of a videoconferencing CBT intervention for anxiety in people with Parkinson’s Disease

2023

Journal Article

Levetiracetam for the treatment of mild cognitive impairment in Parkinson's disease: a double-blind controlled proof-of-concept trial protocol

Dissanayaka, Nadeeka, Pourzinal, Dana, Byrne, Gerard J., Yang, Jihyun, McMahon, Katie L., Pontone, Gregory M., O'Sullivan, John D., Adam, Robert, Littleford, Roberta, Chatfield, Mark, Lehn, Alexander, Mari, Zoltan and Bakker, Arnold (2023). Levetiracetam for the treatment of mild cognitive impairment in Parkinson's disease: a double-blind controlled proof-of-concept trial protocol. Pilot and Feasibility Studies, 9 (1) 189, 189. doi: 10.1186/s40814-023-01406-y

Levetiracetam for the treatment of mild cognitive impairment in Parkinson's disease: a double-blind controlled proof-of-concept trial protocol

2023

Journal Article

Pareidolias are a function of visuoperceptual impairment

McCann, Emily, Lee, Soohyun, Coleman, Felicia, O’Sullivan, John D. and Nestor, Peter J. (2023). Pareidolias are a function of visuoperceptual impairment. PLoS One, 18 (11) e0293942, 1-11. doi: 10.1371/journal.pone.0293942

Pareidolias are a function of visuoperceptual impairment

2023

Journal Article

Longitudinal follow up of data‐driven cognitive subtypes in Parkinson's disease

Pourzinal, Dana, Yang, Jihyun, Sivakumaran, Kumareshan, McMahon, Katie L., Mitchell, Leander, O'Sullivan, John D., Byrne, Gerard J. and Dissanayaka, Nadeeka N. (2023). Longitudinal follow up of data‐driven cognitive subtypes in Parkinson's disease. Brain and Behavior, 13 (10) e3218, e3218. doi: 10.1002/brb3.3218

Longitudinal follow up of data‐driven cognitive subtypes in Parkinson's disease

2023

Journal Article

Global assessment, cognitive profile, and characteristics of mild cognitive impairment in Parkinson's disease

Yang, Jihyun, Pourzinal, Dana, Byrne, Gerard J., McMahon, Katie L., Copland, David A., O’Sullivan, John D., Mitchell, Leander and Dissanayaka, Nadeeka N. (2023). Global assessment, cognitive profile, and characteristics of mild cognitive impairment in Parkinson's disease. International Journal of Geriatric Psychiatry, 38 (6) e5955, e5955. doi: 10.1002/gps.5955

Global assessment, cognitive profile, and characteristics of mild cognitive impairment in Parkinson's disease

2023

Conference Publication

Pareidolias are related to visuoperceptual ability

McCann, Emily, Lee, Soohyun, Coleman, Felicia, O'Sullivan, John and Nestor, Peter (2023). Pareidolias are related to visuoperceptual ability. Australia Dementia Research Forum, Gold Coast, QLD Australia, 29 - 31 May 2023.

Pareidolias are related to visuoperceptual ability

2023

Journal Article

A review of RRx-001: a late-stage multi-indication inhibitor of NLRP3 activation and chronic inflammation

Jayabalan, Nanthini, Oronsky, Bryan, Cabrales, Pedro, Reid, Tony, Caroen, Scott, Johnson, Aishwarya M., Birch, Natalia A., O’Sullivan, John D. and Gordon, Richard (2023). A review of RRx-001: a late-stage multi-indication inhibitor of NLRP3 activation and chronic inflammation. Drugs, 83 (5), 389-402. doi: 10.1007/s40265-023-01838-z

A review of RRx-001: a late-stage multi-indication inhibitor of NLRP3 activation and chronic inflammation

2023

Conference Publication

Case Study: Patient HL, Parkinson’s Disease

McCann, Emily, Lee, Soohyun, Coleman, Felicia, O'Sullivan, John and Nestor, Peter (2023). Case Study: Patient HL, Parkinson’s Disease. Cognition and Basal Ganglia Club, Brisbane, QLD Australia, March 2023.

Case Study: Patient HL, Parkinson’s Disease

2023

Conference Publication

Pareidolias as misperceptions in Lewy Body Disorders

McCann, Emily, Lee, Soohyun, Coleman, Felicia, O'Sullivan, John and Nestor, Peter (2023). Pareidolias as misperceptions in Lewy Body Disorders. Clem Jones Centre for Ageing and Dementia Research (CJCADR) Scientific Symposium, Brisbane, QLD Australia, 9 February 2023.

Pareidolias as misperceptions in Lewy Body Disorders

2022

Conference Publication

Update on TRIP: Therapy to reduce dementia risk in Parkinson’s disease proof of concept trial

Pourzinal, D., Bakker, A., Byrne, G.J., McMahon, K., O’Sullivan, J.D., Adam, R., Lehn, A., Copland, D., Yang, J.H., Au, T., Littleford, R., Chatfield, M., Pontone, G., Mari, Z. and Dissanayaka, N. (2022). Update on TRIP: Therapy to reduce dementia risk in Parkinson’s disease proof of concept trial. UQ Centre for Clinical Research HDR Symposium, Brisbane, QLD Australia, 24 November 2022.

Update on TRIP: Therapy to reduce dementia risk in Parkinson’s disease proof of concept trial

2022

Journal Article

Semantic fluency deficits and associated brain activity in Parkinson’s disease with mild cognitive impairment

Yang, Jihyun, McMahon, Katie L., Copland, David A., Pourzinal, Dana, Byrne, Gerard J., Angwin, Anthony J., O’Sullivan, John D. and Dissanayaka, Nadeeka N (2022). Semantic fluency deficits and associated brain activity in Parkinson’s disease with mild cognitive impairment. Brain Imaging and Behavior, 16 (6), 1-12. doi: 10.1007/s11682-022-00698-7

Semantic fluency deficits and associated brain activity in Parkinson’s disease with mild cognitive impairment

2022

Conference Publication

LC-MS based urine metabolomic profiling indicate altered gut microbiome and host lipid metabolites in Parkinson's disease

Jewell, Shannon, Roper, Kerry, Woodhouse, Helen, Adam, Robert, O'Sullivan, John and Gordon, Richard (2022). LC-MS based urine metabolomic profiling indicate altered gut microbiome and host lipid metabolites in Parkinson's disease. Experimental Biology 2022 Meeting, Philadelphia, PA United States, 2-5 April 2022. Hoboken, NJ United States: John Wiley and Sons. doi: 10.1096/fasebj.2022.36.S1.R2928

LC-MS based urine metabolomic profiling indicate altered gut microbiome and host lipid metabolites in Parkinson's disease

2022

Conference Publication

A Novel Role for Glucocerebrosidase 1 (GBA1) in Parkinson's Disease

Jayabalan, Nanthini, Roper, Katherine Kerry, Woodhouse, Helen M., Adam, Robert J., O'Sullivan, John D. and Gordon, Richard (2022). A Novel Role for Glucocerebrosidase 1 (GBA1) in Parkinson's Disease. Experimental Biology Meeting 2022, Philadelphia, PA United States, 2-5 April 2022. Hoboken, NJ United States: John Wiley and Sons. doi: 10.1096/fasebj.2022.36.S1.R5391

A Novel Role for Glucocerebrosidase 1 (GBA1) in Parkinson's Disease

2022

Journal Article

Caring for a loved one with Parkinson’s disease: the role of coping styles and relationship quality

Zhang, Angeline, Mitchell, Leander K., Pachana, Nancy A., Yang, Ji Hyun J., Au, Tiffany R., Byrne, Gerard J., O’Sullivan, John D. and Dissanayaka, Nadeeka N. (2022). Caring for a loved one with Parkinson’s disease: the role of coping styles and relationship quality. International Psychogeriatrics, 34 (7) PII S1041610221002866, 1-8. doi: 10.1017/s1041610221002866

Caring for a loved one with Parkinson’s disease: the role of coping styles and relationship quality

2022

Conference Publication

Update on TRIP: Therapy to reduce dementia risk in Parkinson’s disease proof of concept trial

Pourzinal, D., Bakker, A., Byrne, G.J., McMahon, K., O’Sullivan, J.D., Adam, R., Lehn, A., Copland, D., Yang, J.H., Au, T., Littleford, R., Chatfield, M., Pontone, G., Mari, Z. and Dissanayaka, N. (2022). Update on TRIP: Therapy to reduce dementia risk in Parkinson’s disease proof of concept trial. UQ Neurosciences Symposium, Brisbane, QLD Australia, 26-27 September 2022.

Update on TRIP: Therapy to reduce dementia risk in Parkinson’s disease proof of concept trial